138 related articles for article (PubMed ID: 7370953)
1. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
[TBL] [Abstract][Full Text] [Related]
2. Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2061-73. PubMed ID: 7370952
[TBL] [Abstract][Full Text] [Related]
3. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
[TBL] [Abstract][Full Text] [Related]
4. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
Das SN; Khanna NN; Khanna S
Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
[TBL] [Abstract][Full Text] [Related]
5. Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.
Stein JA; Adler A; Efraim SB; Maor M
Cancer; 1976 Sep; 38(3):1171-87. PubMed ID: 953963
[TBL] [Abstract][Full Text] [Related]
6. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
7. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
[TBL] [Abstract][Full Text] [Related]
8. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
Cancer Immunol Immunother; 1986; 21(1):6-11. PubMed ID: 3632917
[TBL] [Abstract][Full Text] [Related]
10. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of postoperative irradiation on the immune functions in patients with mammary carcinoma.
Toivanen A; Nordman E
Acta Radiol Oncol; 1981; 20(2):119-24. PubMed ID: 6270963
[TBL] [Abstract][Full Text] [Related]
12. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
Wiltschke C; Krainer M; Budinsky AC; Berger A; Müller C; Zeillinger R; Speiser P; Kubista E; Eibl M; Zielinski CC
Br J Cancer; 1995 Jun; 71(6):1292-6. PubMed ID: 7779726
[TBL] [Abstract][Full Text] [Related]
13. Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters.
Wanebo HJ; Rosen PP; Thaler T; Urban JA; Oettgen HF
Ann Surg; 1976 Sep; 184(3):258-67. PubMed ID: 962394
[TBL] [Abstract][Full Text] [Related]
14. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
Willner J; Kiricuta IC; Kölbl O
Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status.
Magrath IT; Simon RM
Int J Cancer; 1976 Oct; 18(4):399-408. PubMed ID: 977186
[TBL] [Abstract][Full Text] [Related]
16. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
17. Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma.
Lee YT
J Surg Oncol; 1984 Nov; 27(3):135-40. PubMed ID: 6492808
[TBL] [Abstract][Full Text] [Related]
18. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
19. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
20. Blood lymphocyte counts with subset analysis in operable breast cancer. Relation to the extent of tumor disease and prognosis.
Rotstein S; Blomgren H; Petrini B; Wasserman J; Nilsson B; Baral E
Cancer; 1985 Sep; 56(6):1413-9. PubMed ID: 4027876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
